AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Pancreas Registry and High Risk Registry

Recruitingn/aAges 18 Years - anyAllIcahn School of Medicine at Mount Sinai
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to establish a registry of patients with pancreatic diseases. Patients included in the registry may include those with: pancreatic cancer, precancerous lesions of the pancreas, inflammatory lesions of the pancreas, cystic lesions of the pancreas, and patients at high-risk of pancreatic cancer such as those with a family history of pancreatic cancer or with a family history of a syndrome known to be associated with pancreatic cancer. Pancreatic cancer is the fourth leading cause of death from cancer in the United States. However, little is known about the development of pancreatic cancer and pancreatic diseases in individuals with the above conditions. Knowledge of how family history, environmental exposures, and inflammatory lesion of the pancreas contribute to the development of pancreatic cancer and pancreatic diseases is essential. You may qualify to take

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * At least 1 first degree relative affected with Pancreatic Cancer * Any of (BRCA1, BRCA2, PALB2, ATM) mutations + 1 family member with Pancreatic Cancer * mFAMMM (p16,CDKN2A mutations) + 1 family member with Pancreatic cancer * Known mutation carrier for STK11 (Peutz Jeghers Syndrome) * Lynch syndrome (HNPCC) + 1 family PDAC * Known mutation carrier for Hereditary pancreatitis * Individuals with a history of pancreatic cyst(s) (IPMN's) that measure โ‰ฅ 1 cm Exclusion Criteria: * Patients who do not speak English or Spanish * Refusal by patient * Individuals under the age of 18 years
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

2 sites
Mount Sinai West
New York, United States
Icahn School of Medicine at Mount Sinai
New York, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy